You are here: Home

 Welcome to Elite Pharmaceuticals

 
 

Elite Pharmaceuticals, Inc. specializes in the development of oral controlled release products, such as delayed, sustained, targeted and pulsatile release tablets, pellets, capsules, granules and powders.  The Company’s primary focus is in the therapeutic areas of pain management, allergy, cardiovascular and infection.

 
       Click here to be directed to Elite's 2014 Annual Meeting Information

 


Recent Press Releases:
7/15/2014 Elite Pharmaceuticals Initiates Pivotal Bioequivalence Study for ELI-201

6/30/2014 Elite Pharmaceuticals, Inc. Reports Financial Results for the Fiscal Year Ended March 31, 2014
Revenues Increase by 35%, Product Development Accelerating
Conference Call Scheduled for Tuesday, July 1 at 12:00 PM EDT


6/26/2014 Elite Pharmaceuticals, Inc. to Host 2014 Fiscal Year End Conference Call on Tuesday, July 1, 2014
….Fiscal Year Ended March 31, 2014 Financials Are Scheduled To Be Filed on Monday, June 30, 2014


6/10/2014 Elite Pharmaceuticals Enters Into $5 Million Settlement Agreement with Novel Laboratories

6/9/2014 Elite Pharmaceuticals Begins Human Abuse Liability Studies for ELI-200

 

Elite Pharmaceuticals, Inc. 165 Ludlow Ave., Northvale, NJ 07647    Phone:  201-750-2646  Fax:  201-750-2755 
E Mail:  webmaster@elitepharma.com